A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.

We have successfully established a novel nomogram for predicting OS and CSS in PG-DLBCL patients with good accuracy, which can help physicians to quickly and accurately complete the evaluation of survival probability, risk stratification, and therapeutic strategy at diagnosis.